Source: International Congress 2014 – Systemic biomarkers for airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Ivancsó, G. Toldi, A. Bohács, N. Eszes, V. Müller, J. Rigó Jr., B. Vásárhelyi, G. Losonczy, L. Tamási (Budapest, Hungary). Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy. Eur Respir J 2014; 44: Suppl. 58, 3991

Member's Comments

No comment yet.

Related content which might interest you: Plasma levels of soluble urokinase plasminogen activator receptor (suPAR) as a possible biomarker for lung cancer and/or COPD Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Relation of plasma osteopontin levels with the clinical course in patients with COPD Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in exacerbated COPD Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations Year: 2013 Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Increased serum levels of soluble IL-18 receptor complex in allergic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Soluble urokinase-type plasminogen activator receptor in monitoring of treatment response in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 SERPINE1 -675 4G/5G polymorphism is associated with asthma severity and inhaled corticosteroid response Source: Eur Respir J 2011; 38: 1036-1043 Year: 2011 Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Altered P2 receptor expression profile in sputum cells of patients with COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Concentration of C-reactive protein (CRP) in elderly asthmatics Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Correlation between asthma control and serum levels of IL-33 in atopic asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Assessment of serum magnesium level in patients with bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016